Junghanss Thomas, da Silva Antonio Menezes, Horton John, Chiodini Peter L, Brunetti Enrico
Section of Clinical Tropical Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Am J Trop Med Hyg. 2008 Sep;79(3):301-11.
Clinical management of cystic echinococcosis (CE) has evolved over decades without adequate evaluation of important features such as efficacy, effectiveness, rate of adverse reactions, relapse rate, and cost. CE occurs in health care environments as different as Europe/North America and resource-poor countries of the South and the East. This creates setting-specific problems in the management of patients. Furthermore, studies carried out in either of the two fundamentally different environments lack external validity, i.e., results obtained in one setting may be different from those in the other and practices that can work in one may not be applicable to the other. In this paper, we review the current management procedures of CE with particular emphasis on the evidence base and setting-specific problems.
几十年来,囊性棘球蚴病(CE)的临床管理不断发展,但对疗效、有效性、不良反应发生率、复发率和成本等重要特征却缺乏充分评估。CE在欧洲/北美以及南方和东方资源匮乏国家等不同的医疗环境中均有发生。这给患者管理带来了因环境而异的问题。此外,在这两种截然不同的环境中开展的研究缺乏外部效度,即一种环境中获得的结果可能与另一种环境中的结果不同,在一种环境中行之有效的做法可能不适用于另一种环境。在本文中,我们回顾了CE的当前管理程序,特别强调了证据基础和因环境而异的问题。